VistaGen Therapeutics Inc (VTGN) — Capital Reinvestment Ratio

Latest as of September 2020: 0.10x

VistaGen Therapeutics Inc (VTGN) has a Capital Reinvestment Ratio of 0.10x as of September 2020, meaning it reinvests 0% of its operating cash flow ($1.00 Million) in capital expenditures ($98.80K). See cash generation quality of VistaGen Therapeutics Inc to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

0.10x

Capex / Operating Cash Flow

Operating Cash Flow

$1.00 Million

USD

Capital Expenditures

$98.80K

USD

Data as of

Sep 2020

Most recent filing

Annual Capital Reinvestment Ratio for VistaGen Therapeutics Inc (None–None)

Year-by-year Capital Reinvestment Ratio for VistaGen Therapeutics Inc from None to None. For live market cap and broader valuation context, see VTGN company net worth.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow